No. of Pipelines deployed (median) (range) | 1 (1–14) |
Adjunctive coiling | 40 (31%) |
Procedures with covered branches | 103 (79.8%) |
No. of covered branches (median) (range) | 2 (0–6) |
Last angiographic follow-up (median) (range) (mo)a | 11 (1–72) |
Follow-up aneurysm occlusion ratea | |
Complete (100%) | 85 (66.4%) |
Near-complete (90%–99%) | 15 (11.7%) |
Partial (<90%) | 28 (21.9%) |
Retreatment | |
Endovascular | 11 (8.4%) |
Outcome of covered branchesb | 228 |
Occluded (overall) | 25 (11%) |
VA | 23 |
Occluded | 8 (34.8%) |
PICA | 49 |
Occluded | 4 (8.2%) |
AICA | 78 |
Occluded | 6 (7.7%) |
SCA | 61 |
Occluded | 3 (4.9%) |
PCA | 17 |
Occluded | 4 (23.5%) |
Last clinical follow-up (median) (range) (mo)c | 8 (0.3–72) |
Posttreatment mRSc | |
0–2 | 99 (79.2%) |
3–5 | 12 (9.6%) |
6 (Death) | 14 (11.2%) |
Follow-up mRSc | |
Improved | 43 (34.4%) |
No change | 54 (43.2%) |
Worsened | 28 (22.4%) |
Ischemic complications | 29 (22.5%) |
Timing | |
Intraprocedural | 2 (1.6%) |
Postprocedural | 27 (20.9%) |
Location | |
Brain stem | 13 (10.1%) |
Cerebellum | 13 (10.1%) |
PCA territory | 10 (7.8%) |
Symptomatic | 17 (13.2%) |
Temporary | 6 (4.7%) |
Permanent | 11 (8.5%) |
Territory of ischemic complications | |
Same as covered branch | 21 (72.4%) |
Different | 8 (27.6%) |